268 related articles for article (PubMed ID: 32119141)
1. Subacute cutaneous lupus erythematosus with positive anti-Ro antibodies following palbociclib and letrozole treatment: A case report and literature review.
Russell-Goldman E; Nazarian RM
J Cutan Pathol; 2020 Jul; 47(7):654-658. PubMed ID: 32119141
[TBL] [Abstract][Full Text] [Related]
2. Subacute Cutaneous Lupus Erythematosus Induced by Palbociclib.
Pinard J; Patel M; Granter SR; Vleugels RA; Merola JF
J Cutan Med Surg; 2018; 22(3):341-343. PubMed ID: 29307217
[No Abstract] [Full Text] [Related]
3. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
[TBL] [Abstract][Full Text] [Related]
4. Anastrozole-induced subacute cutaneous lupus erythematosus.
Fisher J; Patel M; Miller M; Burris K
Cutis; 2016 Aug; 98(2):E22-6. PubMed ID: 27622265
[TBL] [Abstract][Full Text] [Related]
5. Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
Collada Sánchez VL; Álvarez Criado J; Martinez Martin V; Zamora Auñon P; Espinosa Arranz E; Mayor Ibarguren A; Nacher Jimenez I; Herrero Ambrosio A
J Oncol Pharm Pract; 2023 Oct; 29(7):1793-1796. PubMed ID: 37455486
[TBL] [Abstract][Full Text] [Related]
6. Taxane associated subacute cutaneous lupus erythematosus.
Marchetti MA; Noland MM; Dillon PM; Greer KE
Dermatol Online J; 2013 Aug; 19(8):19259. PubMed ID: 24021438
[TBL] [Abstract][Full Text] [Related]
7. Subacute cutaneous lupus erythematosus.
David-Bajar KM
J Invest Dermatol; 1993 Jan; 100(1):2S-8S. PubMed ID: 8423385
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole.
McCourt C; Somerville J; McKenna K
Eur J Dermatol; 2010; 20(6):860-1. PubMed ID: 20974555
[No Abstract] [Full Text] [Related]
9. Terbinafine-induced subacute cutaneous lupus erythematosus.
Bonsmann G; Schiller M; Luger TA; Ständer S
J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
[TBL] [Abstract][Full Text] [Related]
10. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
[TBL] [Abstract][Full Text] [Related]
11. Acebutolol-induced subacute cutaneous lupus erythematosus.
Fenniche S; Dhaoui A; Ammar FB; Benmously R; Marrak H; Mokhtar I
Skin Pharmacol Physiol; 2005; 18(5):230-3. PubMed ID: 16015021
[TBL] [Abstract][Full Text] [Related]
12. [Subacute cutaneous lupus erythematosus induced by terbinafine].
Amitay-Layish I; Feuerman H; David M
Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
[TBL] [Abstract][Full Text] [Related]
13. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced lupus erythematosus.
Marzano AV; Tavecchio S; Menicanti C; Crosti C
G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced cutaneous lupus erythematosus: 88 new cases.
Laurinaviciene R; Sandholdt LH; Bygum A
Eur J Dermatol; 2017 Feb; 27(1):28-33. PubMed ID: 27799135
[TBL] [Abstract][Full Text] [Related]
17. Palbociclib-induced subacute cutaneous lupus erythematosus.
Carrasquilla-Capilla A; Crumbach L; Neuhart A; Amini-Adle M
Ann Dermatol Venereol; 2024 Jun; 151(2):103260. PubMed ID: 38507957
[No Abstract] [Full Text] [Related]
18. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus.
Valeski JE; Kumar V; Forman AB; Beutner EH; Chorzelski TP
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):194-8. PubMed ID: 1430355
[TBL] [Abstract][Full Text] [Related]
19. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
Chlebus E; Wolska H; Blaszczyk M; Jablonska S
J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
[TBL] [Abstract][Full Text] [Related]
20. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus.
Magro CM; Crowson AN
Am J Dermatopathol; 1999 Apr; 21(2):129-37. PubMed ID: 10218672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
